We found that DGAT1 is overexpressed in tumor tissues from GBM patients and genetic or pharmacological inhibition of DGAT1, but not DGAT2, suppresses LD/TAG formation and reduces GBM tumor growth (Figure 3) [17]. Here, DGAT2 is linked to glioblastoma.